Rhoen Klinikum AG
DUS:RHK

Watchlist Manager
Rhoen Klinikum AG Logo
Rhoen Klinikum AG
DUS:RHK
Watchlist
Price: 12.3 EUR 0.82% Market Closed
Market Cap: €823.3m

Wall St Price Targets

RHK Price Targets Summary
Rhoen Klinikum AG

Wall Street analysts forecast RHK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RHK is 13.85 EUR with a low forecast of 12.1 EUR and a high forecast of 16.11 EUR.

Lowest Forecast
Price Target
12.1 EUR
2% Downside
Average Forecast
Price Target
13.85 EUR
13% Upside
Highest Forecast
Price Target
16.11 EUR
31% Upside
Rhoen Klinikum AG Competitors:
Price Targets
FCL
FINEOS Corporation Holdings PLC
69% Upside
NVT
nVent Electric PLC
12% Upside

Revenue
Forecast

-3% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-3% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 3 years is 5%.

Gross Profit
Forecast

-4% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
-4% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been -4%. The projected CAGR for the next 5 years is -4%.

Operating Income
Forecast

-11% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
-11% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 14 years, the compound annual growth rate for Operating Income has been -11%. The projected CAGR for the next 3 years is 24%.

Pre-Tax Income
Forecast

-10% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
-10% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -10%. The projected CAGR for the next 3 years is 19%.

Net Income
Forecast

-10% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat
-10% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat

Over the last 14 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RHK's stock price target?
Price Target
13.85 EUR

According to Wall Street analysts, the average 1-year price target for RHK is 13.85 EUR with a low forecast of 12.1 EUR and a high forecast of 16.11 EUR.

What is the Revenue forecast for Rhoen Klinikum AG?
Projected CAGR
5%

Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Rhoen Klinikum AG?
Projected CAGR
-4%

Over the last 14 years, the compound annual growth rate for Gross Profit has been -4%. The projected CAGR for the next 5 years is -4%.

What is the Operating Income forecast for Rhoen Klinikum AG?
Projected CAGR
24%

Over the last 14 years, the compound annual growth rate for Operating Income has been -11%. The projected CAGR for the next 3 years is 24%.

What is the Pre-Tax Income forecast for Rhoen Klinikum AG?
Projected CAGR
19%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -10%. The projected CAGR for the next 3 years is 19%.

What is the Net Income forecast for Rhoen Klinikum AG?
Projected CAGR
20%

Over the last 14 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett